ACL Stock Overview
Australian Clinical Labs Limited provides pathology services in Australia.
Australian Clinical Labs Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$3.19|
|52 Week High||AU$6.39|
|52 Week Low||AU$3.12|
|1 Month Change||-5.62%|
|3 Month Change||-24.05%|
|1 Year Change||-26.50%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-6.73%|
Recent News & Updates
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention TodayAug 14
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?Feb 25
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)Dec 22
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do MoreDec 21
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The BusinessSep 01
|ACL||AU Healthcare||AU Market|
Return vs Industry: ACL underperformed the Australian Healthcare industry which returned -16.4% over the past year.
Return vs Market: ACL underperformed the Australian Market which returned -1.1% over the past year.
|ACL Average Weekly Movement||6.2%|
|Healthcare Industry Average Movement||5.3%|
|Market Average Movement||9.0%|
|10% most volatile stocks in AU Market||16.0%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: ACL is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ACL's weekly volatility (6%) has been stable over the past year.
About the Company
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals.
Australian Clinical Labs Limited Fundamentals Summary
|ACL fundamental statistics|
Is ACL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ACL income statement (TTM)|
|Cost of Revenue||AU$232.98m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 23, 2023
|Earnings per share (EPS)||0.89|
|Net Profit Margin||17.90%|
How did ACL perform over the long term?See historical performance and comparison